常用静脉腔内激光消融参数不影响疗效:系统评价与荟萃分析
该系统评价与荟萃分析纳入28项随机对照试验共2829条大隐静脉,评估静脉腔内激光消融(EVLA)的成功率及不同参数的影响。总体成功率为92%(95%CI 90-94%),波长、能量、随访时间和结局定义均无显著差异,低偏倚风险研究成功率更高。
要点
- EVLA总体成功率高(92%),即使随访时间延长。
- 常用参数(波长、能量、结局定义)对成功率无显著影响。
- 低偏倚风险研究报告的成功率显著高于高/不清楚偏倚风险研究。
核心结论
- EVLA总体成功率为92%,常用参数(波长、能量、结局定义)不影响治疗成功率。
主要发现
- EVLA总体成功率为92%(95%CI 90-94%,I2=68%)。
关键数值与推荐
- 亚组分析波长分组:短波长(810、940、980 nm),长波长(1470、1500、1920 nm)。
- 能量分组:≤50 J/cm与>50 J/cm。
- 随访分组:≤1年与>1年。
- 结局定义分组:闭塞与无返流。
- 研究质量分组:低偏倚风险与不清楚/高偏倚风险。
临床怎么用
- 临床中常用EVLA参数(波长、能量)的选择可能无需过度关注对成功率的影响。
- 应优先参考低偏倚风险研究的结果,因其报告的成功率更高。
- EVLA总体成功率高,可作为大隐静脉功能不全的有效治疗选择。
局限性
- 研究间异质性较高(I2=68%)。
- 仅纳入随访超过3个月的RCT,可能遗漏短期结果。
- 部分亚组分析样本量有限,解释需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of this systematic review and meta-analysis was to summarise available randomised controlled trials (RCTs) of EVLA efficacy, and to define the differences in success rate of variations in wavelength, administered energy, outcome definition, and follow up period. METHODS: A literature search was conducted in Embase, Medline (Ovid-SP), Cochrane Central Database, and Web of Science from inception to November 2017. RCTs with follow up of more than three months were included. The studied outcome was the proportion of patients with EVLA treatment success, defined as absence of reflux or occlusion of the great saphenous vein (GSV). Pooled proportions of anatomical success were compared. Subgroup and meta-regression analysis included wavelengths (short [810, 940, and 980 nm], long [1470, 1500, and 1920 nm]), amount of energy (≤50 J/cm, > 50 J/cm), follow up (≤1 year, > 1 year), outcome definition (occlusion, no reflux), and quality of the studies (low risk of bias, unclear/high risk of bias). RESULTS: Twenty-eight RCTs, with a total of 2829 GSVs were included. The overall success rate of EVLA was 92% (95% CI 90-94%, I2 = 68%). In subgroup analysis, no statistically significant differences were found for long or short wavelengths (95% [95% CI 91-97%] vs. 92% [95% CI 89-94%], p = .15), high or low administered energy (93% [95% CI 89-95%] vs. 92% [95% CI 90-94%], p = .99), long or short follow up (89% [95% CI 84-93%] vs. 93% [95% CI 91-95%], p = .13) and outcome definition (occlusion group 94% [95% CI 91-96%] vs. absence of reflux group 91% [95% CI 87-94%], p = .26). Studies with low risk of bias reported a significantly higher success rate than high or unclear risk of bias (93% [95% CI 90-95%] vs. 89% [95% CI 83-93%], p = .04). CONCLUSIONS: The overall success rate of EVLA is high (92%), even with increasing follow up. Commonly used parameters of EVLA (wavelength, administered energy, and outcome definition) have no influence on the treatment success rate.
引用
- Malskat WSJ, Engels LK, Hollestein LM, et al. Commonly Used Endovenous Laser Ablation (EVLA) Parameters Do Not Influence Efficacy: Results of a Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2019. PMID: 31230868. doi:10.1016/j.ejvs.2018.10.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。